Jeffrey R Brashear

Title: Innovations by Jeffrey R. Brashear

Introduction

Jeffrey R. Brashear is an accomplished inventor based in Mundelein, IL (US). He has made significant contributions to the field of immunoassays, particularly in the detection of cardiac troponin-T (cTnT). With a total of 2 patents, his work has advanced diagnostic methods in healthcare.

Latest Patents

One of his latest patents is titled "Assay for cardiac troponin-T (cTnT)." This patent describes immunoassays designed to detect cTnT in test samples, especially those that may contain substances interfering with the determination of cTnT. The methods utilize multiple capture phase antibodies and detection antibodies to enhance specificity. Additionally, humanized immunoreagents are employed to mitigate interferences from heterophilic antibodies. Another notable patent is "Autoantibody enhanced immunoassays and kits," which provides immunoassays and kits for detecting or quantifying analytes in samples that may contain autoantibodies reactive with the analyte.

Career Highlights

Jeffrey R. Brashear is associated with Abbott Laboratories Corporation, a leading company in the healthcare sector. His work at Abbott has focused on developing innovative diagnostic solutions that improve patient outcomes.

Collaborations

Throughout his career, Jeffrey has collaborated with notable colleagues, including Maciej B. Adamczyk and Phillip G. Mattingly. These collaborations have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Jeffrey R. Brashear's contributions to the field of immunoassays exemplify the impact of innovation in healthcare diagnostics. His patents reflect a commitment to improving the accuracy and reliability of medical testing.